Embla Medical
Klaus S. is an experienced finance professional specializing in investor relations, business development, and mergers and acquisitions. Currently serving as the Head of Investor Relations at Embla Medical since May 2024, Klaus previously held the same position at Hansa Biopharma from April 2019 to May 2024. A career at Novozymes lasted from 2006 to 2018, where Klaus progressed through roles such as Senior Manager in Investor Relations and Acquisition Manager, overseeing significant transactions including EMD CropBioscience for $283 million. Earlier professional experiences include roles as Business Development Director at Royal Unibrew, M&A Analyst at DSP Corporate Finance, Project Controller at TDC, and Auditor at Ernst & Young. Klaus S. holds a Master's degree in Finance from Copenhagen Business School and has completed further education at MIT Sloan School of Management, ICAEW, and Fudan University.
This person is not in any teams
This person is not in any offices
Embla Medical
2 followers
In Nordic mythology, Embla was the first woman on Earth. Made from the wood of the ancient Elm tree, she became a symbol of new life. Of breath, movement and freedom. Today, she embodies who we are. Our vision and our values. At Embla Medical, we are dedicated to improving people’s mobility. We do this with compassion and innovation, from how we design our award-winning mobility solutions to how we operate our network of patient care clinics. Embla Medical is home to Össur, a leading global provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels. Since 1971, we have produced more than 2,100 patents and numerous award-winning designs, renowned for advancing the Orthotic & Prosthetic (O&P) industry. Our patient care clinics make up a vast network, spread across multiple countries. They are modern, comfortable spaces where patients have access to innovative solutions, expert guidance, and personalized care and support. Our commitment and responsibility also extends to our people and our planet. We embrace diversity and recognize the impact we have on the world around us. Improving mobility can be a lifelong journey. And we are companions on that journey, committed to providing the best outcomes and highest patient satisfaction. We do this with a successful and growing portfolio of leading brands and a global network of talented teams, all driven by our shared purpose of helping people to live a Life Without Limitations®.